http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2517190-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cce74ae91129e276612f5855529149a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-063 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd3ed04c3b24869d8c1aef95baf0be9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c46fc4510ead8ddfa68bfd8fb0a6fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_159e76046d642623c0c4bca39a2a148e |
| publicationDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2517190-B2 |
| titleOfInvention | Canine mammary inflammatory carcinoma cell line |
| abstract | Canine mammary inflammatory carcinoma cell line # The present invention relates to an established canine mammary inflammatory carcinoma cell line of triple negative basal epithelial cells. The invention also relates to a method for obtaining stable xenotransplants of canine mammary carcinoma in experimental animals, and the use of the cell line and xenotransplants in the study of canine mammary carcinoma as well as human mammary carcinoma. and its use to identify in vitro therapeutically useful compounds for the treatment of human breast inflammatory cancer. It also refers to a kit for the in vitro study of canine BMI and / or human IBC and of potentially usable drugs against human IBC, which includes the cell line of the invention. |
| priorityDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.